|
PODE 2013 Eli Lilly, UK 15 June
2013 |
|
|
9.25 - 9:30 |
Welcome |
|
Session
1 |
|
|
9.30 - 11.00 |
Dave
Woods,
University of Southampton Bayesian
inference and design space identification for nonlinear chemical kinetics (slides) |
|
Tim
Waite,
University of Southampton Integrability and
Bayesian D-optimality (slides) |
|
|
Roger
Jelliffe, University of Southern California Bayes
risk as an alternative to Fisher Information in determining experimental
designs for nonparametric models (slides) |
|
|
11.00 - 11.30 |
Tea/Coffee |
|
Session
2 |
|
|
11.30 - 13.00 |
Francois
Combes, Universite Paris Diderot Influence of study design and associated shrinkage
on power of the tests used for covariate detection in population
pharmacokinetics (slides) |
|
Sebastian
Ueckert, Uppsala
University Improving
cognitive testing with IRT and optimal design (slides) |
|
|
Andy
Hooker,
Uppsala
University Platform
for adaptive optimal design of nonlinear mixed effect models (slides) |
|
|
13.00 -
14.00 |
Lunch |
|
Session
3 |
|
|
14.00 - 15.30 |
Iftakhar Alam, Queen Mary, University of London Adaptive
dose finding in early phase clinical trials incorporating pharmacokinetic
information (slides) |
|
Vlad Dragalin, Aptiv Solutions Adaptive population enrichment design in
confirmatory clinical trials (slides) |
|
|
Steve
Duffull, University of Otago Designing a pilot study using
adaptive DP-optimality (slides) |
|
|
15.30 -
16.00 |
TEA/COFFEEE |
|
Session
4 |
|
|
16.00 - 16.30 |
|
|
Barbara
Bogacka and Iva Gueorguieva, Queen Mary, University of
London and Eli Lilly General
Discussion |
|
|
~ PODE ~ |
|